This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Covid-19
Risk of severe COVID-19 increased by physical inactivity
Read more
Red algae component as potential preventative agent in COVID-19
Read more
CCK-A agonist reduces disease severity in moderate COVID
Read more
Higher levels of UVA associated with lower COVID-19 mortality
Read more
Inhaled budesonide appears to prevent worsening of COVID-19
Read more
A third of patients have neurological or psychiatric diagnoses after COVID-19 infection
Read more
Over a million people in the UK estimated to have long COVID
Read more
Study finds low level of adherence to the UK Test, Trace and Isolate system
Read more
Three-factor model predicts those with COVID-19 at high risk of thromboembolism
Read more
Poor antibody response in transplant patients despite COVID-19 vaccination
Read more
More than half of the population in England have COVID-19 antibodies
Read more
Vaccination leads to higher T cell response in those previously infected with COVID-19
Read more
Flu vaccination reduces infection risk and symptom burden of COVID-19
Read more
Infliximab attenuates COVID-19 antibody response
Read more
At least three-quarters of US population at risk of severe COVID-19
Read more
Intermediate and standard-dose prophylactic anticoagulation in COVID-19 equivalent
Read more
Is acute COVID-19 associated with the probability of depressive symptoms?
Read more
Page 15 of 27
« First
«
...
10
...
13
14
15
16
17
...
20
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: